AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: John Russell
Nov. 22--Eli Lilly and Co.'s new diabetes drug Byetta, which became so popular that the company had trouble meeting demand this summer, is about to go international.
The drug, noted for its weight-loss benefits, has been approved for sale in 27 European countries, Lilly said Tuesday. It's the first market outside the United States for the drug, which Lilly is counting on to become a key future source of revenue.
Lilly co-developed Byetta with Amylin Pharmaceuticals, a San Diego-based company.
Byetta is given to diabetic patients to help control their blood-sugar levels before they become insulin-dependent. Many patients…